MNC pharma body OPPI appoints Anil Matai as new director general

The Organisation of Pharmaceutical Producers of India (OPPI), the trade physique that represents world multinational (MNC) pharmaceutical firms, on Monday introduced the appointment of Anil Matai as its director basic.

Anil Matai, a seasoned basic administration skilled, has labored throughout MNCs together with spearheading operations of Novartis India Ltd, GSK India, and World Pharma, Dubai.

After superannuating as managing director of Zydus Healthcare, Anil was engaged as senior advisor – Life Sciences at IQVIA Consulting and Info Providers India Pvt. Ltd., and most not too long ago as working accomplice at Jashvik Capital – a mid-market non-public fairness fund targeted on healthcare and client sector.

Anil has functioned on the boards of Zydus Healthcare Ltd., Bayer Zydus Pharma Personal Ltd., Novartis Healthcare Personal Ltd and Biochem Pharmaceutical Industries Ltd.

“I welcome Anil on board and am assured that together with his breadth of expertise, we can lead OPPI to realize its goal of bringing progressive medicine and new therapies for unmet medical wants and drive key advocacy efforts on IP, innovation, high quality and different areas,” mentioned Suresh Pattathil, president of OPPI.

“He has been a robust voice for healthcare transformation within the nation and below his management we can optimize affected person outcomes by creating an surroundings conducive to innovation and progress, participating productively with authorities stakeholders,” Pattathil added.